Alto Neuroscience, Inc.
ANRO
$2.28
$0.010.44%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.52% | -83.60% | -85.04% | -84.20% | -46.59% |
| Total Depreciation and Amortization | 51.79% | 93.65% | 0.89% | 12.79% | 15.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 159.29% | 348.64% | 112.23% | 298.77% | 2.93% |
| Change in Net Operating Assets | 108.56% | 234.05% | 138.33% | 73.87% | -241.32% |
| Cash from Operations | -12.99% | -51.01% | -76.25% | -45.97% | -91.40% |
| Capital Expenditure | -43.75% | -2,237.21% | -529.63% | -966.67% | -467.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.75% | -2,237.21% | -529.63% | -966.67% | -467.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 68.97% | -38.53% | 41.86% | -- | 625.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 348.21% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 34.11% | 2,183.33% | -213.83% | -- | -1,108.28% |
| Cash from Financing | -99.89% | 2,587.76% | -358.82% | 438.24% | 118.81% |
| Foreign Exchange rate Adjustments | 50.00% | -138.89% | 54.55% | 73.68% | -80.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.10% | -47.54% | -81.80% | 607.43% | 129.03% |